Antibody-Drug Conjugate

ADC

Drug Modalities

An antibody-drug conjugate (ADC) links a targeting antibody to a potent cytotoxic payload, delivering the drug selectively to cells expressing the target antigen. ADCs aim to widen the therapeutic window versus conventional chemotherapy and are a fast-growing oncology modality.

Related terms

CAR-T Cell Therapy Mechanism of Action

Track Antibody-Drug Conjugate across 1,000+ biotechs

BioSniper monitors FDA decisions, clinical trials, and catalysts in real time — with evidence-backed AI analysis.

Start Free